12 Health Care Stocks Moving In Monday's Intraday Session

Loading...
Loading...

Gainers

  • NRX Pharmaceuticals NRXP shares increased by 39.5% to $2.93 during Monday's regular session. The company's market cap stands at $30.9 million.
  • TC BioPharm (Holdings) TCBP stock moved upwards by 35.61% to $1.98. The company's market cap stands at $6.3 million.
  • Outset Medical OM stock rose 26.15% to $3.96. The company's market cap stands at $204.8 million.
  • Nanoviricides NNVC stock moved upwards by 25.66% to $1.42. The market value of their outstanding shares is at $16.7 million.
  • Chemomab Therapeutics CMMB stock rose 22.16% to $0.9. The market value of their outstanding shares is at $12.8 million.
  • Titan Pharma TTNP shares moved upwards by 22.09% to $8.4. The market value of their outstanding shares is at $7.6 million.

Losers

  • Lyra Therapeutics LYRA shares decreased by 86.3% to $0.55 during Monday's regular session. The market value of their outstanding shares is at $33.6 million. As per the news, the Q1 earnings report came out 4 days ago.
  • GlycoMimetics GLYC stock declined by 79.04% to $0.38. The market value of their outstanding shares is at $24.7 million.
  • EyePoint Pharmaceuticals EYPT shares declined by 39.37% to $11.97. The market value of their outstanding shares is at $623.4 million.
  • Acutus Medical AFIB stock fell 27.1% to $0.11. The company's market cap stands at $3.1 million.
  • Integra Lifesciences IART shares declined by 20.46% to $22.98. The company's market cap stands at $1.8 billion. The company's, Q1 earnings came out today.
  • Helius Medical Tech HSDT shares fell 14.81% to $2.44. The company's market cap stands at $2.1 million. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Loading...
Loading...
Market News and Data brought to you by Benzinga APIs
Posted In: MoversBZI-TFM
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

Loading...